In 2018, a headline for an article in The Economist succinctly captured the paradox that is the global cancer industry: “Cancer is a Curse, but Also a Growth Market for Investors.” Cancer’s definitely a curse, that’s for sure, but cancer drugs, with chemotherapy drugs taking up the lion’s share, are on pace to become a $200 billion industry in the next few years, up from $100 billion in 2015.
This is serious growth, and forecasts see global cancer rates exploding in coming years. An investor’s dream, but the reality of cancer treatment is that patients are often unaware of the mortal risks of cancer drugs, especially chemotherapy. In 2017, we reported on a study from the Albert Einstein College of Medicine of Yeshiva University in New York, indicating that chemotherapy often causes cancer to become more aggressive, and can cause tumors to spread.
Many are given chemotherapy before surgery, but the new research suggests that, although it shrinks tumours in the short term, it could trigger the spread of cancer cells around the body.
It is thought the toxic medication switches on a repair mechanism in the body which ultimately allows tumors to grow back stronger. It also increases the number of ‘doorways’ on blood vessels which allow cancer to spread throughout the body. [Source]
This notion is reflected in data in another study, from Public Health England and Cancer Research UK, which looked at 30-day mortality post systemic anticancer treatments (SACT) to determine benchmarks for surviving SACT. The results highlight a critical problem with the cancer industry, the treatment often kills the patient long before the cancer may have.
The study looked at more than 23,000 women with breast cancer and nearly 10,000 men with 9634 non-small cell lung cancer who underwent chemotherapy in 2014. Of those treated 1,383 died within 30 days.
When looking at those death rates across hospitals in the U.K., the researchers found an alarming mortality rate that was directly associated with the chemotherapy treatment.
“England around 8.4 per cent of patients with lung cancer, and 2.4 per cent of breast cancer patients died within a month,” the Telegraph reported.
“But in some hospitals the figure was far higher. In Milton Keynes the death rate for lung cancer treatment was 50.9 per cent, although it was based on a very small number of patients.”
The rates of 30-day post mortality varied significantly among various hospitals, suggesting that chemotherapy practices and procedures are subject to the quality of the facilities and providers. In general, however, it is widely known that chemotherapy is deadly to healthy cells along with tumorous cells.
In other areas including, Blackpool, Coventry, Derby, South Tyneside, Surrey, and Sussex, saw that deaths from lung cancer patients receiving chemotherapy were much higher than the national average.
Cancer Lead for Public Health England, Dr. Jem Rashbass, requested the study and said, according to the Telegraph: “Chemotherapy is a vital part of cancer treatment and is a large reason behind the improved survival rates over the last four decades.”
“However, it is powerful medication with significant side effects and often getting the balance right on which patients to treat aggressively can be hard.”
“Those hospitals whose death rates are outside the expected range have had the findings shared with them and we have asked them to review their practice and data.”
“All women with breast cancer and all men and women with lung cancer residing in England, who were 24 years older and who started a cycle” of chemotherapy in 2014 were included in the analysis by the researchers of the study. [Source]
It’s a bit of a touchy subject for doctors who want the best for their patients, but are working within a system that promotes chemotherapy and immunotherapy drugs as the best treatments. Perhaps, though, they are the best treatments among the field of legal options for treating cancer.
Persecution for attempting to heal patients with alternative, nutritional or holistic treatments is severely punished by the FDA, who is charged with approving treatments. There are many possibilities for treating cancer once you abandon the medical establishment, among them holding great promise is medicinal cannabis.
The original article can be found by clicking here.